ScoreWhy is Shanghai Runda Medical Technology Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 2.67% and Operating profit at -19.19% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 12.29% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 2.67% and Operating profit at -19.19% over the last 5 years
3
With a fall in Operating Profit of -36.28%, the company declared Very Negative results in Mar 25
- The company has declared negative results for the last 8 consecutive quarters
- ROCE(HY) Lowest at -0.85%
- DEBTORS TURNOVER RATIO(HY) Lowest at 1.4%
- RAW MATERIAL COST(Y) Grown by 19.66% (YoY)
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -18.07%, its profits have fallen by -118.1%
- At the current price, the company has a high dividend yield of 0.2
5
Underperformed the market in the last 1 year
- Even though the market (China Shanghai Composite) has generated returns of 14.77% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -18.07% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shanghai Runda Medical Technology Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shanghai Runda Medical Technology Co., Ltd.
-18.07%
-0.07
44.59%
China Shanghai Composite
14.77%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.67%
EBIT Growth (5y)
-19.19%
EBIT to Interest (avg)
2.47
Debt to EBITDA (avg)
5.08
Net Debt to Equity (avg)
1.29
Sales to Capital Employed (avg)
0.80
Tax Ratio
100.00%
Dividend Payout Ratio
32.75%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.23%
ROE (avg)
12.29%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.17
EV to EBIT
67.88
EV to EBITDA
23.37
EV to Capital Employed
1.50
EV to Sales
1.95
PEG Ratio
NA
Dividend Yield
0.19%
ROCE (Latest)
2.21%
ROE (Latest)
-1.48%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
CASH AND EQV(HY)
Highest at CNY 2,327.64 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 131.26 %
-32What is not working for the Company
ROCE(HY)
Lowest at -0.85%
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.4%
RAW MATERIAL COST(Y)
Grown by 19.66% (YoY
NET SALES(Q)
Lowest at CNY 1,654.91 MM
OPERATING PROFIT(Q)
Lowest at CNY -14.58 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -0.88 %
PRE-TAX PROFIT(Q)
Lowest at CNY -69.39 MM
NET PROFIT(Q)
Lowest at CNY -69.26 MM
EPS(Q)
Lowest at CNY -0.11
Here's what is working for Shanghai Runda Medical Technology Co., Ltd.
Cash and Eqv
Highest at CNY 2,327.64 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 131.26 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Shanghai Runda Medical Technology Co., Ltd.
Net Sales
At CNY 1,654.91 MM has Fallen at -19.96%
over average net sales of the previous four periods of CNY 2,067.7 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Pre-Tax Profit
At CNY -69.39 MM has Fallen at -217.09%
over average net sales of the previous four periods of CNY 59.26 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -69.26 MM has Fallen at -601.14%
over average net sales of the previous four periods of CNY 13.82 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Debtors Turnover Ratio
Lowest at 1.4% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Net Sales
Lowest at CNY 1,654.91 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY -14.58 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at -0.88 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY -69.39 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY -69.26 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY -0.11
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Raw Material Cost
Grown by 19.66% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
